Section one: Contracting authority/entity
one.1) Name and addresses
NHS Norfolk and Waveney Integrated Care Board
8th Floor, County Hall, Martineau Lane
Norwich
NR1 2DH
Country
United Kingdom
Region code
UKH15 - Norwich and East Norfolk
Internet address(es)
Main address
https://www.improvinglivesnw.org.uk/
Buyer's address
Section two: Object
two.1) Scope of the procurement
two.1.1) Title
Provision of Hypertension and Lipids Optimisation Project
Reference number
NW2025-89
two.1.2) Main CPV code
- 85100000 - Health services
two.1.3) Type of contract
Services
two.1.4) Short description
NHS Norfolk and Waveney Integrated Care Board is seeking a procure a Hypertension and Lipids Optimisation Project. The successful provider staff will be expected to work with the ICB Cardiovascular disease team, the N&W Protect NoW team, and General Practice to improve clinical effectiveness through case finding and management of patients.
NHS Norfolk and Waveney Integrated Care Board is seeking to launch a large-scale CVD Prevention project using a Population Health Management approach to case finding and intervention. The project will focus on hypertension and lipid management, with patients being identified and subsequently risk-stratified using the ICB software.
The ABCDE program aims to improve the care of patients at risk of Cardiovascular events through case finding and improved management of high-risk individuals. This project is considered a system priority to see our population lead healthier, longer lives, whilst simultaneously reducing pressures on the health system through early detection and management.
The successful provider is expected to supply and manage Clinical Prescribers who will liaise with the ICB Protect NoW team, General Practice, and patients. A personalised care approach will be used to support pharmacological and social prescribing for our patient cohort.
Prescribers must be able to initiate relevant medicines.
Prescribers must initiate medicines in line with N&W criteria.
Patients will be identified using the ICB’s population health management software (Eclipse). The ICB Protect NoW Team will contact patients via digital (and print, if necessary) mediums to inform them of their relative risks and changes they can make in their lifestyles and diets and to encourage medication adherence where necessary.
Patients identified as eligible for medication will be consented by Protect NoW and subsequently made available to the provider, and the prescribers are to systematically contact this patient cohort and seek to initiate and / or optimise treatment in line with ICB and national guidance.
The provider will be expected to liaise with the relevant Practice where required on necessary ongoing management and monitoring.
Section six. Complementary information
six.6) Original notice reference
Notice number: 2025/S 000-009953
Section seven. Changes
seven.1.2) Text to be corrected in the original notice
Section number
IV.2.2.1
Instead of
Date
11 April 2025
Local time
5:00pm
Read
Date
28 April 2025
Local time
5:00pm